Patient-Derived Organoids For Infections, Disease Modeling, And Drug Testing

Patient-derived organoids are transforming how we study infections, diseases, and new treatments. These miniature, lab-grown versions of human tissues allow us to explore how infections develop, how the body responds, and why some diseases progress. My team develops and uses these 3D organoid models together with mice models to better understand the interactions between harmful microbes, the immune system, and tissue health. With advanced technologies like high-resolution imaging and genetic analysis, we aim to uncover disease mechanisms and identify better ways to detect and treat illnesses. This research also helps in testing new drugs, making treatments more precise and effective for patients.